Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Cancer

Explore clinical trials studying Pancreatic Cancer. Study availability and eligibility vary by location and protocol.

1,289 public trials 285 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Cancer trial results

Completed

Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas

NCT01298401

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
  • James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

NCT00005832

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Veterans Affairs Outpatient Clinic - Martinez Martinez, California, United States
  • University of California Davis Medical Center Sacramento, California, United States
  • CCOP - Central Illinois Decatur, Illinois, United States
View all 14 locations
View Trial Details
Completed

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

NCT00075686

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • East Alabama Medical Center Opelika, Alabama, United States
  • Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
  • Cancer Center at Providence Alaska Medical Center Anchorage, Alaska, United States
View all 389 locations
View Trial Details
Completed

A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival

NCT00461708

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Alcoy, Alicante, Spain
  • Elche, Alicante, Spain
  • Palma de Mallorca, Balearic Islands, Spain
  • Barcelona, Spain
View all 29 locations
View Trial Details
Completed

MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery

NCT01098344

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Addenbrooke's Hospital Cambridge, England, United Kingdom
  • Leicester Royal Infirmary Leicester, England, United Kingdom
  • Barts and the London School of Medicine London, England, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom
View Trial Details

Related conditions